FMR LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 1 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$036
+3500.0%
0.00%
Q2 2021$0
-100.0%
1
-100.0%
0.00%
Q3 2018$873,000
-13.4%
226,844
-24.0%
0.00%
Q2 2018$1,008,000
+1801.9%
298,644
+1094.6%
0.00%
Q1 2018$53,000
-98.0%
25,000
-97.1%
0.00%
Q1 2016$2,671,000
-29.9%
867,314
-12.4%
0.00%
-100.0%
Q4 2015$3,812,000
+25.2%
990,014
-0.8%
0.00%
Q3 2015$3,045,000
-31.0%
998,314
-4.0%
0.00%
-100.0%
Q2 2015$4,410,000
-33.8%
1,040,114
-39.7%
0.00%0.0%
Q1 2015$6,659,000
+1.8%
1,725,253
+77.6%
0.00%0.0%
Q4 2014$6,539,000
+79.6%
971,601
+46.5%
0.00%
Q3 2014$3,641,000
-46.4%
663,2390.0%0.00%
-100.0%
Q2 2014$6,798,000
-19.9%
663,239
-6.2%
0.00%0.0%
Q1 2014$8,492,000
+6.2%
707,0390.0%0.00%0.0%
Q4 2013$7,997,000
-8.5%
707,039
-12.8%
0.00%0.0%
Q3 2013$8,736,000
+6.1%
811,139
-8.7%
0.00%0.0%
Q2 2013$8,232,000888,0390.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Perceptive Advisors 6,574,060$27,874,0001.68%
SENZAR ASSET MANAGEMENT, LLC 798,381$3,385,0000.58%
Cormorant Asset Management, LP 850,000$3,604,0000.48%
Palo Alto Investors LP 2,135,739$9,056,0000.40%
Opus Point Partners Management, LLC 99,959$424,0000.34%
Granahan Investment Management 1,582,237$6,709,0000.19%
Joel Isaacson & Co., LLC 70,660$300,0000.08%
MARINER INVESTMENT GROUP LLC 59,700$253,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$318,0000.06%
Cornerstone Capital, Inc. 59,200$251,0000.06%
View complete list of ACELRX PHARMACEUTICALS INC shareholders